Related Experiment Video
Updated: May 2, 2026

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
Peripheral Neuromodulation for Spasticity
Salvatore Facciorusso1, Stefania Spina1, Nicoletta Cinone1
1Physical Medicine and Rehabilitation Section, Department of Medical and Surgical Sciences, University of Foggia, Foggia 71122, Italy; Spinal Cord Rehab. and Functional Recovery Section- Azienda Ospedaliero-Universitaria "Policlinico Foggia", Viale Luigi Pinto 1, Foggia 71122, Italy.
Abstract:
This narrative review synthesizes current understanding of peripheral neuromodulation for spasticity. It navigates the spectrum of electrical and mechanical techniques, elucidating their operative mechanisms and clinical utility. The potential of peripheral neuromodulation to refine spasticity management through targeted, nonpharmacological interventions, thereby enhancing functional outcomes within neurorehabilitation, has been emphasized.
More Related Videos
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Alterations in Muscle Tone ll
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Skeletal Muscle Relaxants: Therapeutic Uses
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...

